Research Overview and Discussion of Application of AE-IPF(Lung Heat and Collateral Obstruction Syndrome)Combined with Disease and Syndrome Biomarkers
- VernacularTitle:AE-IPF肺热络瘀证病证结合生物标志物的研究概况及应用探析
- Author:
Yuru WANG
1
;
Yaqin WANG
;
Yingjie LI
;
Linlin WANG
;
Ningzi ZANG
;
Lijian PANG
Author Information
- Keywords: Idiopathic pulmonary fibrosis acute exacerbation period; Lung heat and collateral obstruction syndrome; Syndrome-biomarker combination; Biomarker
- From: World Science and Technology-Modernization of Traditional Chinese Medicine 2024;26(8):2030-2035
- CountryChina
- Language:Chinese
- Abstract: Idiopathic pulmonary fibrosis(IPF)is a progressive and inflammatory interstitial lung disease,clinically divided into stable and acute exacerbation periods of idiopathic pulmonary fibrosis(AE-IPF),which faces great difficulties in prevention and treatment,increasing the health and life burden of patients.At present,the diagnostic methods of AE-IPF are relatively limited,while biomarkers are safe,simple and specific,which are of great significance for the diagnosis and treatment of AE-IPF.Based on the theoretical connotation of AE-IPF(lung heat and collateral obstruction syndrome),this paper explores the application value of combining AE-IPF lung heat stagnation syndrome and biomarkers,explains the pathogenesis of AE-IPF lung heat stagnation syndrome at the molecular level,and analyzes the guiding role of combining syndromes and biomarkers in the clinical application of traditional Chinese medicine for AE-IPF lung heat stagnation syndrome.
